Biomarkers in the Critically Ill Patient: Procalcitonin

Critical Care Clinics

Volumn 27, Issue 2, 2011, Pages 253-263

  Reinhart, Konrad ^a   Meisner, Michael ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Staedtisches Krankenhaus Dresden Neustadt   (Germany)

Author keywords

Antibiotic; Biomarker; Procalcitonin; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; LIPOPOLYSACCHARIDE BINDING PROTEIN; PROCALCITONIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL INFECTION; CLINICAL FEATURE; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FOLLOW UP; HORMONE BLOOD LEVEL; INFLAMMATION; INTENSIVE CARE; LABORATORY TEST; LOWER RESPIRATORY TRACT INFECTION; MEDICATION ERROR; MYCOSIS; PANCREATITIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRANSPLANTATION; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS; BIOLOGICAL MARKERS; CALCITONIN; CRITICAL ILLNESS; HUMANS; PROGNOSIS; PROTEIN PRECURSORS; SEPSIS;

EID: 79953001345     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2011.01.002     Document Type: Review

References (75)

1. Bohoun C., Petitjean S., Assicot M. Blood procalcitonin is a new biological marker of the human septic response. New data on the specificity. Clin Intens Care 1994, 5(Suppl 2):88.
2. Becker K., Müller B., Nylen E., et al. Calcitonin gene family of peptides. Principles and practice of endocrinology and metabolism 2001, 520-534. J.B. Lippincott Co, Philadelphia. 3rd edition. K. Becker (Ed.).
3. Sexton P.M., Christopoulous G., Christopoulous A., et al. Procalcitonin has bioactivity at calcitonin receptor family complexes: potential mediator implications in sepsis. Crit Care Med 2008, 36:1637-1640.
4. Hoffmann G., Totzke G., Seibel M., et al. In vitro modulation of inducible nitric oxide synthase gene expression and nitric oxide synthesis by procalcitonin. Crit Care Med 2001, 29:112-116.
5. Linscheid P., Seboek D., Schaer J.D., et al. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and macrophage-activated adipocytes. Crit Care Med 2004, 32:1715-1721.
6. Müller B., Becker K.L., Schächinger H., et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000, 28(4):977-983.
7. Ugarte H., Silva E., Mercan D., et al. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999, 27:498-504.
8. Suprin K., Camus C., Gacoucin A., et al. Procalcitonin: a valuable indicator of infection in a medical ICU?. Intensive Care Med 2000, 26:1232-1238.
9. Selberg O., Hecker H., Martin M., et al. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 2000, 28:2793-2798.
10. Harbarth S., Holeckova K., Froidevaux C., et al. Diagnostic value of procalcitonin, interleukin-6 and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001, 164:396-402.
11. Castelli G.P., Pognani C., Meisner M., et al. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004, 8:R234-R240.
12. Zeni F., Viallon A., Assicot M., et al. Procalcitonin serum concentrations and severity of sepsis. Clin Intens Care 1994, 5(Suppl 2):89-98.
13. Al-Nawas B., Krammer I., Shah P.M. Procalcitonin in diagnosis of severe infections. Eur J Med Res 1996, 1:331-333.
14. Uzzan B., Cohen R., Nicolas P., et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006, 34(7):1-8.
15. Bohuon C., Assicot M., Raymond J., et al. Procalcitonin, a marker of bacterial meningitis in children in childhood. Bull Acad Natl Med 1998, 182:1469-1475.
16. Prat C., Dominguez J., Rodrigo C., et al. Use of quantitative and semiquantitative procalcitonin measurements to identify children with sepsis and meningitis. Eur J Clin Microbiol Infect Dis 2004, 23:136-138.
17. Mueller C., Huber P., Laifer G., et al. Procalcitonin and the early diagnosis of infective endocarditis. Circulation 2004, 109:1707-1710.
18. Gras-le-Guen C., Delmas C., Launay E., et al. Contribution of procalcitonin to occult bacteremia detection in children. Scand J Infect Dis 2007, 39:157-159.
19. Wanner G.A., Keel M., Steckholzer U., et al. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 2000, 28:950-957.
20. Schröder J., Staubach K.H., Zabel P., et al. Procalcitonin as a marker of severity in septic shock. Langenbecks' Arch Surg 1999, 384:33-38.
21. Seligman R., Meisner M., Lisboa T.C., et al. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 2006, 10:R125.
22. Luyt C.E., Guerin V., Combes A., et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2005, 171:48-53.
23. Chastre J., Luyt C.E., Trouillet J.L., et al. New diagnostic and prognostic markers of ventilator-associated pneumonia. Curr Opin Crit Care 2006, 124:446-451.
24. Jensen J.U., Heslet L., Jensen T.H., et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006, 34:2596-2602.
25. Hatherill M., Shane M.T., Turner C., et al. Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit Care Med 2000, 28:2591-2594.
26. Christ-Crain M., Jaccard-Stolz D., Bingisser R., et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster randomised, single-blinded intervention trial. Lancet 2004, 363:6000-6007.
27. Briel M., Schuetz P., Mueller B., et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008, 168:2000-2007.
28. Stolz D., Christ-Crain M., Bingisser R., et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 2007, 131:9-19.
29. Schuetz P., Christ-Crain M., Thomann R., et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections. JAMA 2009, 302:1059-1066.
30. Kylänpää-Bäck M.L., Takala A., Kamppainen E.A., et al. Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med 2001, 29:63-69.
31. Kylänpää-Bäck M.L., Takala A., Kemppainen E., et al. Procalcitonin strip test in the early detection of severe acute pancreatitis. Br J Surg 2000, 88:1-6.
32. Bülbüller N., Doǧru O., Ayten R., et al. Procalcitonin is a predictive marker for severe acute pancreatitis. Ulus Travma Acil Cerrahi Derg 2006, 12(2):115-120.
33. Rau B., Kemppainen E.A., Gumps A.A., et al. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT). Ann Surg 2007, 245:745-754.
34. Riche F.C., Cholley B.P., Laisne M.J.C., et al. Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis. Surgery 2003, 133:257-262.
35. Purkayastha S., Chow A., Athanasiou T., et al. Does serum procalcitonin have a role in evaluating the severity of acute pancreatitis? A question revisited. World J Surg 2006, 30:1713-1721.
36. Distefano G., Curreri R., Betta P., et al. Procalcitonin serum levels in perinatal bacterial and fungal infection of preterm infants. Acta Paediatr 2004, 93:216-219.
37. Christofilopoulou S., Charvalos E., Petrikkos G. Could procalcitonin be a predictive biological marker in systemic fungal infections?. Eur J Intern Med 2002, 13:493-495.
38. Jemli B., Aouni Z., Lebben I., et al. [Procalcitonine et candidoses invasives en milieu de reanimation]. Ann Biol Clin (Paris) 2007, 65:169-173. [in French].
39. Han Y.Y., Doughty L.A., Kofos D., et al. Procalcitonin is persistently increased among children with poor outcome from bacterial sepsis. Pediatr Crit Care Med 2003, 4:21-25.
40. Gerard Y., Hober D., Petitjean S., et al. High serum procalcitonin level in a 4-year old liver transplant recipient with disseminated candidiasis [letter]. Infection 1995, 23:310-311.
41. Bell K., Wattie M., Byth K., et al. Procalcitonin: a marker of bacteraemia and SIRS. Anaesth Intensive Care 2003, 31:629-636.
42. Chan Y.L., Tseng C.P., Tsay P.K., et al. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care 2004, 8(1):R12-R20.
43. Caterino J.M., Scheatzle M.D., Forbes M.L., et al. Bacteremic elder emergency department patients: procalcitonin and white count. Acad Emerg Med 2004, 11(4):393-396.
44. Liaudat S., Dayer E., Praz G., et al. Usefulness of procalcitonin serum level for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis 2001, 20:524-527.
45. Chirouze C., Schuhmacher H., Rabaud C., et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patient with acute fever. Clin Infect Dis 2002, 35:156-161.
46. Persson L., Engervall P., Magnuson A., et al. Use of inflammatory markers for early detection of bacteremia in patients with febrile neutropenia. Scand J Infect Dis 2004, 36:365-371.
47. Jimeno A., Garcia-Valasco A., Del Val O., et al. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. Cancer 2004, 100:2462-2469.
48. Hammer S., Meisner F., Dirschedl P., et al. Procalcitonin: a new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation. Transpl Immunol 1998, 6:235-241.
49. Hammer S., Meisner F., Dirschedl P., et al. Procalcitonin: a new marker for diagnosis of acute rejection and becterial infection in patients after heart and lung transplantation. Transpl Immunol 2006, 6:235-241.
50. Fazakas J., Gondos T., Varga M., et al. Analysis of systemic and regional procalcitonin serum levels during liver transplantation. Transpl Int 2003, 16(7):465-470.
51. Kuse E.R., Langefeld I., Jaeger K., et al. Procalcitonin in fever of unknown origin (FUO) following liver transplantation - a parameter to differentiate acute rejection from infection. Intensive Care Med 2000, (Suppl 2):S187-S192.
52. Qedra N., Wagner F., Jonitz B., et al. Procalcitonin (PCT) is a new biological marker for the diagnosis of non-viral infections after transplantation of intrathoracic organs. J Heart Lung Transplant 2001, 20(2):239.
53. Wagner F.D., Jonitz B., Potapov E., et al. Procalcitonin: a donor-specific predictor of early graft failure-related mortality after heart transplantation. J Heart Lung Transplant 2001, 2:206. [abstract].
54. Al-Nawas B., Shah P.M. Procalcitonin in patients with and without immunosuppression and sepsis. Infection 1996, 24:434-436.
55. Oberhoffer M., Bitterlich A., Hentschel T., et al. Procalcitonin (ProCT) correlates better with the ACCP/SCCM consensus conference definitions than other specific markers of the inflammatory response. Clin Intens Care 1996, 7(Suppl 1):46.
56. De Talance N., Burlet C., Claudel C. La procalcitonine (PCT) est-elle le marqueur specifique du choc septique?. Immunoanalyse et Biologie Specialisee 2003, 18:120-122. [in French].
57. Brunkhorst F.M., Wegscheider K., Forycki Z.F., et al. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2000, 26(Suppl):S148-S152.
58. Okada Y., Minakami H., Tomomasa T., et al. Serum procalcitonin concentrations in patients with Kawasaki disease. J Infect 2003, 48:199-205.
59. Ciaccio M., Fugardi G., Titone L., et al. Procalcitonin levels in plasma in oncohaematological patients with and without bacterial infections. Clin Chim Acta 2004, 340:149-152.
60. Tang B.M., Eslick G.D., Craig J.C., et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7:210-217.
61. Gendrel D., Raymond J., Assicot M., et al. Measurement of procalcitonin levels in children with bacterial and viral meningitis. Clin Infect Dis 1997, 24:1240-1242.
62. Eberhard O.K., Haubitz M., Brunkhorst F.M., et al. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmatic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997, 40:1250-1256.
63. Eberhard O.K., Langefeld I., Kuse E., et al. Procalcitonin in the early phase after renal transplantation - will it add to diagnostic accuracy?. Clin Transplant 1998, 12:206-211.
64. Hedlund J., Hansson L.O. Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis. Infection 2000, 28:68-73.
65. Moulin F., Raymond J., Lorrot M., et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child 2001, 84:332-336.
66. Lacour A.G., Gervaix A., Zamora S.A., et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur J Pediatr 2001, 160:95-100.
67. Rau B., Steinbach G., Baumgart K., et al. The clinical value of procalcitonin in the prediction of infected necrosis in acute pancreatitis. Intensive Care Med 2000, 26:S159-S164.
68. Ilhan N., Ilhan N., Ilhan Y., et al. C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. World J Gastroenterol 2004, 10(8):1115-1120.
69. Matzaraki V., Alexandraki K., Venetsanou K., et al. Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis. Clin Biochem 2007, 40:336-342.
70. Bouadma L., Luyt C.E., Tubach F., et al, PRORATA trial group Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010, 375(9713):463-474.
71. Gibot S. Procalcitonin in intensive care units: the PRORATA trial. Lancet 2010, 375:1605-1606.
72. Tarnow-Mordi W., Gebski V. Procalcitonin in intensive care units: the PRORATA trial. Lancet 2010, 375:1605.
73. Schuetz P., Albrich W., Christ-Crain M., et al. Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther 2010, 8:575-587.
74. Holm A., Pedersen S.S., Nexoe J., et al. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care. Br J Gen Pract 2007, 57:555-560.
75. Cals J.W., Butler C.C., Hopstaken R.M., et al. Effect of point-of-care testing for C-reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ 2009, 338:1374.